Clinical Trial Update: Expanded Access Program:Lenalidomide With or Without Dexamethasone In Previously Treated Subjects With Multiple Myeloma [Phase 3]

View source ↗

Summary

Phase 3 expanded-access trial evaluating lenalidomide with or without dexamethasone in previously treated multiple myeloma completed, with results posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Decadron (Dexamethasone)
• Revlimid (lenalidomide)

Snippet

Sponsor: Celgene Corporation | Conditions: Multiple Myeloma | Phase 3 | Status: COMPLETED | Results posted: 2010-03-03